These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11814786)

  • 1. Synthesis of fluorescent biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.
    Burnett DA; Caplen MA; Browne ME; Zhau H; Altmann SW; Davis HR; Clader JW
    Bioorg Med Chem Lett; 2002 Feb; 12(3):315-8. PubMed ID: 11814786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of iodinated biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.
    Burnett DA; Caplen MA; Domalski MS; Browne ME; Davis HR; Clader JW
    Bioorg Med Chem Lett; 2002 Feb; 12(3):311-4. PubMed ID: 11814785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats.
    van Heek M; Farley C; Compton DS; Hoos LM; Smith-Torhan A; Davis HR
    Br J Pharmacol; 2003 Apr; 138(8):1459-64. PubMed ID: 12721101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezetimibe and other azetidinone cholesterol absorption inhibitors.
    Clader JW
    Curr Top Med Chem; 2005; 5(3):243-56. PubMed ID: 15857308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: enhanced potency by modification of the sugar.
    Vaccaro WD; Davis HR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):313-8. PubMed ID: 9871676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe analogs with a reorganized azetidinone ring: Design, synthesis, and evaluation of cholesterol absorption inhibitions.
    Xu X; Fu R; Chen J; Chen S; Bai X
    Bioorg Med Chem Lett; 2007 Jan; 17(1):101-4. PubMed ID: 17049851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a biotin-tagged photoaffinity probe of 2-azetidinone cholesterol absorption inhibitors.
    Frick W; Bauer-Schäfer A; Bauer J; Girbig F; Corsiero D; Heuer H; Kramer W
    Bioorg Med Chem; 2003 Apr; 11(8):1639-42. PubMed ID: 12659749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of inhibitors of intestinal cholesterol absorption.
    Kvaernø L; Werder M; Hauser H; Carreira EM
    J Med Chem; 2005 Sep; 48(19):6035-53. PubMed ID: 16162006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Azetidinone cholesterol absorption inhibitors: increased potency by substitution of the C-4 phenyl ring.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem; 1998 Sep; 6(9):1429-37. PubMed ID: 9801814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function.
    van Heek M; Farley C; Compton DS; Hoos L; Davis HR
    Br J Pharmacol; 2001 Sep; 134(2):409-17. PubMed ID: 11564660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxy-substituted 2-azetidinones as cholesterol absorption inhibitors.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem Lett; 1998 Feb; 8(3):319-22. PubMed ID: 9871677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption.
    Rosenblum SB; Huynh T; Afonso A; Davis HR; Yumibe N; Clader JW; Burnett DA
    J Med Chem; 1998 Mar; 41(6):973-80. PubMed ID: 9526571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of binding proteins for cholesterol absorption inhibitors as components of the intestinal cholesterol transporter.
    Kramer W; Glombik H; Petry S; Heuer H; Schäfer H; Wendler W; Corsiero D; Girbig F; Weyland C
    FEBS Lett; 2000 Dec; 487(2):293-7. PubMed ID: 11150527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 2-azetidinone and 1H-pyrrole-2,5-dione derivatives containing sulfonamide group at the side chain as potential cholesterol absorption inhibitors.
    Yuan X; Lu P; Xue X; Qin H; Fan C; Wang Y; Zhang Q
    Bioorg Med Chem Lett; 2016 Feb; 26(3):849-853. PubMed ID: 26783178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted 2-azaspiro[5.3]nonan-1-ones as potent cholesterol absorption inhibitors: defining a binding conformation for SCH 48461.
    Dugar S; Clader JW; Chan TM; Davis H
    J Med Chem; 1995 Dec; 38(25):4875-7. PubMed ID: 8523398
    [No Abstract]   [Full Text] [Related]  

  • 16. An enzymatic synthesis of glucuronides of azetidinone-based cholesterol absorption inhibitors.
    Reiss P; Burnett DA; Zaks A
    Bioorg Med Chem; 1999 Oct; 7(10):2199-202. PubMed ID: 10579526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors.
    Vaccaro WD; Sher R; Davis HR
    Bioorg Med Chem Lett; 1998 Jan; 8(1):35-40. PubMed ID: 9871624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual screening for cholesterol absorption inhibitors.
    Sun L; Qian H; Huang W
    Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A formal synthesis of ezetimibe via cycloaddition/rearrangement cascade reaction.
    Michalak M; Stodulski M; Stecko S; Mames A; Panfil I; Soluch M; Furman B; Chmielewski M
    J Org Chem; 2011 Aug; 76(16):6931-6. PubMed ID: 21744801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of C3 heteroatom-substituted azetidinones that display potent cholesterol absorption inhibitory activity.
    McKittrick BA; Ma K; Huie K; Yumibe N; Davis H; Clader JW; Czarniecki M; McPhail AT
    J Med Chem; 1998 Feb; 41(5):752-9. PubMed ID: 9513603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.